23-Mar-2026 5:00 AM CST - Business Wire Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that holders of common shares of Organigram ("Shareholders") vote FOR the ordinary resolution (the "Transaction Resolution") to approve the indirect acquisition of Sanity Group GmbH ("Sanity") at the Company's Annu
10-Feb-2026 5:00 AM CST - Business Wire Organigram Reports First Quarter Fiscal 2026 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 (Q1 Fiscal 2026 or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-
3-Feb-2026 5:00 AM CST - Business Wire Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call,
16-Dec-2025 5:00 AM CST - Business Wire Organigram Reports Record Fourth Quarter and Fiscal 2025 Results Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 (Q4 Fiscal 2025 or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$"). FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS Gross Revenue: $123.3 million (+76% year-over-year). Net Reven
5-Dec-2025 5:00 AM CST - Business Wire Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share1, announced today it will report earnings results for its fourth quarter fiscal 2025 ended September 30, 2025, on Tuesday, December 16, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, December 16, 2025 Time: 8:00 am Eastern Time To register for the conference cal
13-Aug-2025 5:00 AM CST - Business Wire Organigram Reports Record Third Quarter Fiscal 2025 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share1, is pleased to announce its record results for the third quarter ended June 30, 2025 (Q3 Fiscal 2025 or Q3). Q3 FISCAL 2025 HIGHLIGHTS Record Gross Revenue: $110.2 million (+73% year-over-year, +7.2% sequential). Record Net Revenue: $70.8 million (+72% year-over-year, +7.9% sequential). International Revenue: $7.4 million (+208% year-over-
1-Aug-2025 5:00 AM CST - Business Wire Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its third quarter fiscal 2025 ended June 30, 2025, on Wednesday, August 13, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, August 13, 2025 Time: 8:00 am Eastern Time To register for the conference call, plea
12-May-2025 5:00 AM CST - Business Wire Organigram Reports Record Second Quarter Fiscal 2025 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (Q2 Fiscal 2025). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in
2-May-2025 5:00 AM CST - Business Wire Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use thi
23-Mar-2026 5:00 AM CST - Business Wire Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that holders of common shares of Organigram ("Shareholders") vote FOR the ordinary resolution (the "Transaction Resolution") to approve the indirect acquisition of Sanity Group GmbH ("Sanity") at the Company's Annu
10-Feb-2026 5:00 AM CST - Business Wire Organigram Reports First Quarter Fiscal 2026 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 (Q1 Fiscal 2026 or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-
3-Feb-2026 5:00 AM CST - Business Wire Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call,
16-Dec-2025 5:00 AM CST - Business Wire Organigram Reports Record Fourth Quarter and Fiscal 2025 Results Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 (Q4 Fiscal 2025 or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$"). FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS Gross Revenue: $123.3 million (+76% year-over-year). Net Reven
5-Dec-2025 5:00 AM CST - Business Wire Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share1, announced today it will report earnings results for its fourth quarter fiscal 2025 ended September 30, 2025, on Tuesday, December 16, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, December 16, 2025 Time: 8:00 am Eastern Time To register for the conference cal
13-Aug-2025 5:00 AM CST - Business Wire Organigram Reports Record Third Quarter Fiscal 2025 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share1, is pleased to announce its record results for the third quarter ended June 30, 2025 (Q3 Fiscal 2025 or Q3). Q3 FISCAL 2025 HIGHLIGHTS Record Gross Revenue: $110.2 million (+73% year-over-year, +7.2% sequential). Record Net Revenue: $70.8 million (+72% year-over-year, +7.9% sequential). International Revenue: $7.4 million (+208% year-over-
1-Aug-2025 5:00 AM CST - Business Wire Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its third quarter fiscal 2025 ended June 30, 2025, on Wednesday, August 13, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, August 13, 2025 Time: 8:00 am Eastern Time To register for the conference call, plea
12-May-2025 5:00 AM CST - Business Wire Organigram Reports Record Second Quarter Fiscal 2025 Results Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (Q2 Fiscal 2025). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in
2-May-2025 5:00 AM CST - Business Wire Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use thi
